
It’s hard not to get addicted to this. From side conversations with @MEBirnbaum to an incredible result for patients. So proud of the Kelonia team for all the hard work it took to make this real.
This tweet is unavailable

MD-PhD student @Harvard @MIT | interested in all things immuno, chem bio, viruses, IM, heme/onc, art hist | @Yale '16, NY native | @runthelistpod

It’s hard not to get addicted to this. From side conversations with @MEBirnbaum to an incredible result for patients. So proud of the Kelonia team for all the hard work it took to make this real.
This tweet is unavailable

Check out @Steph_Gaglione's amazing preprint introducing a highly scalable (and inexpensive) approach to TCR synthesis that enables library-on-library screening of TCRs + antigens 👇!
Thrilled to share our preprint! We introduce TCRAFT, a method to assemble tens of thousands of TCRs at <$1 each, unlocking high-throughput functional TCR screening from single-cell data. 🧵@kochinstitute @MEBirnbaum @MITChemE @MIT biorxiv.org/content/10.1101/…

here's a peek of Dr. Perez showing this work - how diverse CAR libraries (inputs) can be leveraged to generate useful datasets that describe differential CAR phenotypes (outputs) at his thesis defense yesterday 👇 super lucky to be your lab mate & play a small part in this work!

An incredibly impressive body of work from the newly-minted PhD @calebrperez comparing clinical candidate CAR-T architectures head-to-head at single cell resolution, shedding light on mechanisms of differential CAR-T efficacy in vivo with insights into better construct design 🚗
Excited to share some of my PhD work was pre-printed! Using single-cell sequencing, we took a deep look at a library of CAR signaling architectures to try to identify signal-intrinsic drivers of CAR-T function🧵👇 @MEBirnbaum @kochinstitute @MITdeptofBE biorxiv.org/content/10.1101/…

In sum, Dezfulian et al. have successfully re-centaured T cell antigen discovery around CD4+ T cells 😉 cell.com/cell-reports-method…

The authors then applied their TScan-II methodology to uncover antigens in cancer, autoimmunity, & infectious disease across many different MHC class II alleles & TCRs Their screens uncovered antigens recognized by clonally-expanded CD4+ T cells from Sjögren's syndrome patients

For their last trick🪄, the authors introduced the candidate human TCR antigen-binding variable region atop a murine TCR constant region resulting in a human-mouse hybrid TCR that reduces cross-reactivity with the endogenous TCR They termed these chimeras "centaur T cells"🏃🐎

For the T cell side of the equation, they made use of the granule-releasing properties of primary CD8+ T cells, but introduced a CD4 co-receptor alongside a candidate T cell receptor (TCR) of interest But what if the introduced TCR mispairs with the endogenous CD8+ T cell's TCR?

They also needed to introduce a reporter of T cell antigen recognition The reporter is an infrared fluorescent protein (IFP) that only becomes fluorescent upon exposure to cytotoxic granzyme B (GzB), representing a functional & sortable readout of cognate CD4+ T cell recognition

But to do so, the authors needed to engineer both the antigen presenting cells (APCs), alongside the primary T cells used For the APCs, they modified HEK-293 cells (eHEK-293-II) to lack MHC class I, but present MHC class II allele(s) of interest alongside appropriate machinery

TScan-II allows for genome-scale interrogation of MHC class II antigens using endogenous processing & presentation machinery of antigen libraries, alongside physiological T cell activation & degranulation (GzB) 👇 pubmed.ncbi.nlm.nih.gov/3801…

Wrote a Spotlight piece together w/ lab mate @amandaochan & @MEBirnbaum covering an impressive new methodology from @elledge_stephen's group that enables MHC class II antigen discovery for CD4+ T cells called TScan-II cell.com/cell-reports-method…

new @runthelistpod episode is now out hosted on @MHMedical's AccessMedicine webpage! best part about it? you can search for key words & phrases to more easily listen to high-yield content 🤯 accessmedicine.mhmedical.com…
We're back with another pod🎙️! Ep 97: Approach to Dysphagia accessmedicine.mhmedical.com… Host @NavinKumarMD discusses dysphagia workup w/ RTL's own @WalkerReddMD

1. ENTER #mRNAvaccines for #pancreaticcancer! Long-term #PDAC survivor story PART3. "Do #PDACs REALLY have vaccine neoantigens (NAs)"? (aren’t they lowly mutated?) If each patient = own NAs, how do you vaccinate? Maybe mRNA? But how? @Nature nature.com/articles/s41586-0… 👇🏽 [1/32]

So excited to be at #SITC22 in Boston hearing from some of the giants in the field!

and there we have it - a "protein PROTAC" that does more than just get degraded in target cells: it protects mice & ferrets from subsequent influenza A challenge demonstrating its ability to serve as a live-attenuated viral vaccine! 💉💉💉